Cernevit Stungulyfsstofn, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cernevit stungulyfsstofn, lausn

baxter medical ab* - vítamín a (palmítat); colecalciferolum inn; vítamín e (tocoferolum nfn); acidum ascorbicum inn; thiaminum cocarboxylase tetrahýdrat; riboflavinum natríumfosfat díhýdrat; pyridoxinum hýdróklóríð; cyanocobalaminum inn; acidum folicum inn; dexpanthenolum inn; biotinum inn; nicotinamidum inn - stungulyfsstofn, lausn

Plenvu Mixtúruduft, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

plenvu mixtúruduft, lausn

norgine b.v. - macrogol 3350; natrii ascorbas inn; sodium sulfate anhydrous; acidum ascorbicum inn; natrii chloridum; kalii chloridum - mixtúruduft, lausn

Moviprep Mixtúruduft, lausn Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

moviprep mixtúruduft, lausn

norgine b.v. - macrogol 3350; natrii sulfas; natrii chloridum; kalii chloridum; acidum ascorbicum inn; natrii ascorbas inn - mixtúruduft, lausn

Attentin Tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 10 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 10 mg

Attentin Tafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 20 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 20 mg

Attentin Tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 5 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 5 mg

Vaxchora Evrópusambandið - íslenska - EMA (European Medicines Agency)

vaxchora

bavarian nordic a/s - vibrio cholerae, álag cvd 103-hgr, lifandi - cholera - bóluefni - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. Þetta bóluefni ætti að vera notuð í samræmi við opinbera tillögur.

Nulibry Evrópusambandið - íslenska - EMA (European Medicines Agency)

nulibry

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.